Australia's largest stock trading and investment forum Australia's #1 stock forum

AT1

4.55%

2.3¢ atomo diagnostics limited

Market cap of $12m with $8m in the bank?, page-117

First 117 Last

Share
Profile

Follow
GT3CAR147

1,107 Posts.

94

06/07/23

10:24

Post #: 68649059
Share

Originally posted by northsydneyboy: ↑

They have FDA clearance, rather than FDA approval I believe.

This is what Bing says when I asked what the difference between FDA clearance and FDA approval was:

"FDA approval and FDA clearance are two different regulatory processes that the FDA uses to evaluate medical devices and drugs. FDA approval is a higher standard because the safety and effectiveness of the specific product has been tested1. The FDA approves drugs, while it clears medical devices2. FDA clearance is a lower standard, and in many cases, the product is cleared because it is similar to an existing product rather than that it has passed rigorous independent safety trials."

this company management track records are extremely bad!

Expand

FDA approval ? not clearance

AT1 Price at posting: 5.9¢ Sentiment: None Disclosure: Not Held
1 Upvote

1 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 59 more messages in this thread...

First 117 Last

Add AT1 (ASX) to my watchlist

(20min delay)
Last 2.3¢		Change 0.001(4.55%)		Mkt cap ! $14.70M

Open	High	Low	Value	Volume
2.0¢	2.3¢	2.0¢	$1.21K	55.02K

Buyers (Bids)

No.	Vol.	Price($)
5	314348	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	152314	2

View Market Depth

No.	Vol.	Price($)
5	314348	0.020
5	604260	0.019
9	1162558	0.018
3	410000	0.017
1	62561	0.016

Price($)	Vol.	No.
0.023	99683	1
0.024	631111	3
0.025	459000	2
0.026	1590045	4
0.027	683000	3

Last trade - 16.10pm 04/10/2024 (20 minute delay)

AT1 (ASX) Chart

Market cap of $12m with $8m in the bank?, page-117

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Market cap of $12m with $8m in the bank?, page-117

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News